Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism

Abstract Metformin is a first-line drug in the treatment of type-2 diabetes mellitus (T2DM). In addition to its antigluconeogenic and insulin-sensitizing properties, metformin has emerged as a potent inhibitor of the chronic inflammatory response of macrophages. In particular, metformin treatment ha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas S. Postler, Vincent Peng, Dev M. Bhatt, Sankar Ghosh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6c9dde354c9449a39ec178a57d0a2807
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6c9dde354c9449a39ec178a57d0a2807
record_format dspace
spelling oai:doaj.org-article:6c9dde354c9449a39ec178a57d0a28072021-12-02T18:14:30ZMetformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism10.1038/s41598-021-97441-x2045-2322https://doaj.org/article/6c9dde354c9449a39ec178a57d0a28072021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97441-xhttps://doaj.org/toc/2045-2322Abstract Metformin is a first-line drug in the treatment of type-2 diabetes mellitus (T2DM). In addition to its antigluconeogenic and insulin-sensitizing properties, metformin has emerged as a potent inhibitor of the chronic inflammatory response of macrophages. In particular, metformin treatment has been shown to reduce expression of interleukin (IL-) 1β during long-term exposure to the pro-inflammatory stimulus lipopolysaccharide (LPS) through a reduction in reactive oxygen species (ROS), which decreases the levels of the hypoxia-inducible factor (HIF) 1-α, and through enhanced expression of IL-10. However, the effect of metformin on the acute inflammatory response, before significant levels of ROS accumulate in the cell, has not been explored. Here, we show that metformin alters the acute inflammatory response through its activation of AMP-activated protein kinase (AMPK), but independently of HIF1-α and IL-10, in primary macrophages and two macrophage-like cell lines. Thus, metformin changes the acute and the chronic inflammatory response through fundamentally distinct mechanisms. Furthermore, RNA-seq analysis reveals that metformin pretreatment affects the levels of a large yet selective subset of inflammatory genes, dampening the response to short-term LPS exposure and affecting a wide range of pathways and biological functions. Taken together, these findings reveal an unexpected complexity in the anti-inflammatory properties of this widely used drug.Thomas S. PostlerVincent PengDev M. BhattSankar GhoshNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Thomas S. Postler
Vincent Peng
Dev M. Bhatt
Sankar Ghosh
Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
description Abstract Metformin is a first-line drug in the treatment of type-2 diabetes mellitus (T2DM). In addition to its antigluconeogenic and insulin-sensitizing properties, metformin has emerged as a potent inhibitor of the chronic inflammatory response of macrophages. In particular, metformin treatment has been shown to reduce expression of interleukin (IL-) 1β during long-term exposure to the pro-inflammatory stimulus lipopolysaccharide (LPS) through a reduction in reactive oxygen species (ROS), which decreases the levels of the hypoxia-inducible factor (HIF) 1-α, and through enhanced expression of IL-10. However, the effect of metformin on the acute inflammatory response, before significant levels of ROS accumulate in the cell, has not been explored. Here, we show that metformin alters the acute inflammatory response through its activation of AMP-activated protein kinase (AMPK), but independently of HIF1-α and IL-10, in primary macrophages and two macrophage-like cell lines. Thus, metformin changes the acute and the chronic inflammatory response through fundamentally distinct mechanisms. Furthermore, RNA-seq analysis reveals that metformin pretreatment affects the levels of a large yet selective subset of inflammatory genes, dampening the response to short-term LPS exposure and affecting a wide range of pathways and biological functions. Taken together, these findings reveal an unexpected complexity in the anti-inflammatory properties of this widely used drug.
format article
author Thomas S. Postler
Vincent Peng
Dev M. Bhatt
Sankar Ghosh
author_facet Thomas S. Postler
Vincent Peng
Dev M. Bhatt
Sankar Ghosh
author_sort Thomas S. Postler
title Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
title_short Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
title_full Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
title_fullStr Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
title_full_unstemmed Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
title_sort metformin selectively dampens the acute inflammatory response through an ampk-dependent mechanism
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6c9dde354c9449a39ec178a57d0a2807
work_keys_str_mv AT thomasspostler metforminselectivelydampenstheacuteinflammatoryresponsethroughanampkdependentmechanism
AT vincentpeng metforminselectivelydampenstheacuteinflammatoryresponsethroughanampkdependentmechanism
AT devmbhatt metforminselectivelydampenstheacuteinflammatoryresponsethroughanampkdependentmechanism
AT sankarghosh metforminselectivelydampenstheacuteinflammatoryresponsethroughanampkdependentmechanism
_version_ 1718378397770448896